Free Trial

Cytosorbents (CTSO) SEC Filings & 10K Form

Cytosorbents logo
$0.98 0.00 (-0.46%)
Closing price 04:00 PM Eastern
Extended Trading
$0.96 -0.02 (-1.79%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cytosorbents SEC Filings

DateFilerForm TypeView
08/20/2025
3:05 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2025
6:33 PM
Cytosorbents (Issuer)
Sobel Alan D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
6:34 PM
Cytosorbents (Issuer)
Deliargyris Efthymios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
6:35 PM
Capponi Vincent (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
6:36 PM
Cytosorbents (Issuer)
Kim Jiny (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
6:37 PM
Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
6:38 PM
BATOR MICHAEL G. (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
6:39 PM
Cytosorbents (Issuer)
Jones Edward Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
6:40 PM
Chan Phillip P. (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:06 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
4:15 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
3:31 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
5:47 PM
Avenue Venture Opportunities Fund, L.P. (Filed by)
Cytosorbents (Subject)
Form SCHEDULE 13G
05/01/2025
3:25 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
3:28 PM
Cytosorbents (Filer)
Form DEFA14A
04/23/2025
3:31 PM
Cytosorbents (Filer)
Form ARS
04/17/2025
3:05 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
1:22 PM
Cytosorbents (Subject)
Skylands Capital, LLC (Filed by)
Form SCHEDULE 13G
04/04/2025
6:05 AM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
4:10 PM
Cytosorbents (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2025
4:12 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
6:00 AM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
8:00 PM
BATOR MICHAEL G. (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:26 PM
Cytosorbents (Issuer)
Sobel Alan D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:27 PM
Chan Phillip P. (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:28 PM
Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:29 PM
Capponi Vincent (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:07 AM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
9:22 AM
AVENIR CORP (Filed by)
Cytosorbents (Subject)
Form SCHEDULE 13G/A
01/31/2025
5:49 PM
Cytosorbents (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G
01/22/2025
7:29 PM
Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:31 PM
Chan Phillip P. (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:32 PM
Cytosorbents (Issuer)
Sobel Alan D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:33 PM
Cytosorbents (Issuer)
Deliargyris Efthymios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:34 PM
Capponi Vincent (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:35 PM
BATOR MICHAEL G. (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
8:05 AM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
12:26 PM
Cytosorbents (Subject)
Skylands Capital, LLC (Filed by)
Form SCHEDULE 13G
12/23/2024
3:05 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
6:00 AM
Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
7:00 AM
Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
6:17 AM
Cytosorbents (Filer)
Form 424B5
12/09/2024
6:18 AM
Cytosorbents (Subject)
Form FWP
12/09/2024
6:08 AM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
8:00 PM
Capponi Vincent (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
8:00 PM
Cytosorbents (Issuer)
Deliargyris Efthymios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:25 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
4:22 PM
Cytosorbents (Filer)
Form 424B5
10/01/2024
7:06 AM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
11:15 PM
Cytosorbents (Filer)
Form EFFECT
09/26/2024
4:05 PM
Cytosorbents (Filer)
Form S-3/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CTSO) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners